AT
Arens Timothy J.
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Arens Timothy J., Chief Financial Officer. Insider active across 3 companies, notably Surmodics INC. Aggregated, 18 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €265k. Activity tracked since 13 May 2021. The latest transaction was filed on 4 December 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
1,265 shares@ US$39.913.0% of flowCommon StockSEC:0000950170-24-134183:0
1,786 shares@ US$39.454.1% of flowCommon StockSEC:0000950170-24-132971:0
7,009 shares@ US$39.442616.4% of flowCommon StockSEC:0000950170-24-131533:0
16,729 shares@ US$40.0638.0% of flowCommon StockSEC:0000950170-24-099117:1
18,447 shares@ US$33.2034.7% of flowCommon StockSEC:0000950170-24-099117:0
8,323 shares0Common StockSEC:0001209191-23-057621:0
650 shares@ US$32.821.2% of flowCommon StockSEC:0001209191-23-057264:0
650 shares@ US$36.131.4% of flowCommon StockSEC:0001209191-22-059494:0
543 shares@ US$36.021.2% of flowCommon StockSEC:0001209191-22-058980:0
151 shares@ US$35.911.6% of flowCommon StockSEC:0001209191-22-029573:0
650 shares@ US$43.938.4% of flowCommon StockSEC:0001209191-21-067515
650 shares@ US$43.937.9% of flowCommon StockSEC:0001209191-21-067515:0
544 shares@ US$47.857.3% of flowCommon StockSEC:0001209191-21-066988:0
544 shares@ US$47.857.7% of flowCommon StockSEC:0001209191-21-066988
12,498 shares@ US$23.9579.4% of flowCommon StockSEC:0001209191-21-054244:0
12,498 shares@ US$23.9583.9% of flowCommon StockSEC:0001209191-21-054244
134 shares@ US$53.241.9% of flowCommon StockSEC:0001209191-21-033012:0
134 shares@ US$53.241.9% of flowCommon StockSEC:0001209191-21-033012
About Arens Timothy J.
Timothy J. Arens is the Chief Financial Officer of SURMODICS INC. He is responsible for the financial management of the company, including budgeting and regulatory compliance.